Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,812Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 88OTSUKA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BREXPIPRAZOLE

US Patent Number : 8618109

Drug Substance Claim :

Drug Product Claim :

Application Number : 205422

Patent Use Code : U-543

Delist Requested :

Patent Use Description : TREATMENT OF SCHIZOPHR...

Patent Expiration Date : 2026-04-12

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BREXPIPRAZOLE

US Patent Number : 8349840

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205422

Patent Use Code : U-1529

Delist Requested :

Patent Use Description : ADJUNCTIVE TREATMENT O...

Patent Expiration Date : 2026-04-12

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BREXPIPRAZOLE

US Patent Number : 8618109

Drug Substance Claim :

Drug Product Claim :

Application Number : 205422

Patent Use Code : U-543

Delist Requested :

Patent Use Description : TREATMENT OF SCHIZOPHR...

Patent Expiration Date : 2026-04-12

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BREXPIPRAZOLE

US Patent Number : 9839637

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205422

Patent Use Code : U-1529

Delist Requested :

Patent Use Description : ADJUNCTIVE TREATMENT O...

Patent Expiration Date : 2026-04-12

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BREXPIPRAZOLE

US Patent Number : 9839637

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205422

Patent Use Code : U-543

Delist Requested :

Patent Use Description : TREATMENT OF SCHIZOPHR...

Patent Expiration Date : 2026-04-12

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BREXPIPRAZOLE

US Patent Number : 9839637

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205422

Patent Use Code : U-1529

Delist Requested :

Patent Use Description : ADJUNCTIVE TREATMENT O...

Patent Expiration Date : 2026-04-12

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BREXPIPRAZOLE

US Patent Number : 9839637

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205422

Patent Use Code : U-543

Delist Requested :

Patent Use Description : TREATMENT OF SCHIZOPHR...

Patent Expiration Date : 2026-04-12

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BREXPIPRAZOLE

US Patent Number : 9839637

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205422

Patent Use Code : U-1529

Delist Requested :

Patent Use Description : ADJUNCTIVE TREATMENT O...

Patent Expiration Date : 2026-04-12

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BREXPIPRAZOLE

US Patent Number : 9839637

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205422

Patent Use Code : U-543

Delist Requested :

Patent Use Description : TREATMENT OF SCHIZOPHR...

Patent Expiration Date : 2026-04-12

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BREXPIPRAZOLE

US Patent Number : 9839637

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205422

Patent Use Code : U-543

Delist Requested :

Patent Use Description : TREATMENT OF SCHIZOPHR...

Patent Expiration Date : 2026-04-12

blank